Harnessing natural products for myocardial infarction therapy: Mechanistic insights and translational opportunities

Myocardial infarction (MI) continues to pose significant challenges in clinical treatment despite medical advancements. Natural products (NPs) derived from botanical and biological sources demonstrate considerable therapeutic potential through their ability to simultaneously address multiple patholo...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengmeng Li, Siyi Wang, Hanya Dong, Min Wang, Ye Sun, Yu Bi, Lixia Chen, Anam Naseem, Hai Jiang, Hua Li, Bingyou Yang, Yan Liu
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661825002270
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850111232167641088
author Mengmeng Li
Siyi Wang
Hanya Dong
Min Wang
Ye Sun
Yu Bi
Lixia Chen
Anam Naseem
Hai Jiang
Hua Li
Bingyou Yang
Yan Liu
author_facet Mengmeng Li
Siyi Wang
Hanya Dong
Min Wang
Ye Sun
Yu Bi
Lixia Chen
Anam Naseem
Hai Jiang
Hua Li
Bingyou Yang
Yan Liu
author_sort Mengmeng Li
collection DOAJ
description Myocardial infarction (MI) continues to pose significant challenges in clinical treatment despite medical advancements. Natural products (NPs) derived from botanical and biological sources demonstrate considerable therapeutic potential through their ability to simultaneously address multiple pathological features of MI. This comprehensive review examines the past decade of research investigating the therapeutic effects of various classes of NPs, notably terpenoids, flavonoids, alkaloids, phenolic acids, and phenylpropanoids in MI treatment. The analysis focuses on their multifaceted mechanisms of action, particularly their capacity to inhibit cellular apoptosis, reduce oxidative damage, attenuate fibrotic development, suppress inflammatory pathways, stimulate vascular regeneration, and normalize calcium homeostasis. Importantly, the discussion critically addresses the current limitations hindering clinical translation of NPs therapies, specifically focusing on bioavailability challenges and insufficient target specificity. Furthermore, this review also explores innovative solutions to these obstacles, particularly the significant importance of advanced drug delivery technologies and NPs for the future of personalized medicine and precision medicine. By systematically evaluating both the fundamental pharmacological properties and practical application barriers of NPs, this work provides valuable insights for future research directions in MI treatment. The synthesis of mechanistic understanding with translational considerations offers a framework for developing NPs-based therapies with improved clinical potential.
format Article
id doaj-art-10d09da2f00c4d2a97e522b634730e26
institution OA Journals
issn 1096-1186
language English
publishDate 2025-07-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj-art-10d09da2f00c4d2a97e522b634730e262025-08-20T02:37:39ZengElsevierPharmacological Research1096-11862025-07-0121710780210.1016/j.phrs.2025.107802Harnessing natural products for myocardial infarction therapy: Mechanistic insights and translational opportunitiesMengmeng Li0Siyi Wang1Hanya Dong2Min Wang3Ye Sun4Yu Bi5Lixia Chen6Anam Naseem7Hai Jiang8Hua Li9Bingyou Yang10Yan Liu11Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, ChinaKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, ChinaKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, ChinaKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, ChinaKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, ChinaKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, ChinaWuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, ChinaKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, ChinaKey Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China; Corresponding authors.Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China; Institute of Structural Pharmacology & TCM Chemical Biology, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China; Corresponding author at: Institute of Structural Pharmacology & TCM Chemical Biology, College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122, China.Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China; Corresponding authors.Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Harbin 150040, China; Corresponding authors.Myocardial infarction (MI) continues to pose significant challenges in clinical treatment despite medical advancements. Natural products (NPs) derived from botanical and biological sources demonstrate considerable therapeutic potential through their ability to simultaneously address multiple pathological features of MI. This comprehensive review examines the past decade of research investigating the therapeutic effects of various classes of NPs, notably terpenoids, flavonoids, alkaloids, phenolic acids, and phenylpropanoids in MI treatment. The analysis focuses on their multifaceted mechanisms of action, particularly their capacity to inhibit cellular apoptosis, reduce oxidative damage, attenuate fibrotic development, suppress inflammatory pathways, stimulate vascular regeneration, and normalize calcium homeostasis. Importantly, the discussion critically addresses the current limitations hindering clinical translation of NPs therapies, specifically focusing on bioavailability challenges and insufficient target specificity. Furthermore, this review also explores innovative solutions to these obstacles, particularly the significant importance of advanced drug delivery technologies and NPs for the future of personalized medicine and precision medicine. By systematically evaluating both the fundamental pharmacological properties and practical application barriers of NPs, this work provides valuable insights for future research directions in MI treatment. The synthesis of mechanistic understanding with translational considerations offers a framework for developing NPs-based therapies with improved clinical potential.http://www.sciencedirect.com/science/article/pii/S1043661825002270Natural productsMyocardial infarctionPathological mechanismTarget identificationDrug delivery system
spellingShingle Mengmeng Li
Siyi Wang
Hanya Dong
Min Wang
Ye Sun
Yu Bi
Lixia Chen
Anam Naseem
Hai Jiang
Hua Li
Bingyou Yang
Yan Liu
Harnessing natural products for myocardial infarction therapy: Mechanistic insights and translational opportunities
Pharmacological Research
Natural products
Myocardial infarction
Pathological mechanism
Target identification
Drug delivery system
title Harnessing natural products for myocardial infarction therapy: Mechanistic insights and translational opportunities
title_full Harnessing natural products for myocardial infarction therapy: Mechanistic insights and translational opportunities
title_fullStr Harnessing natural products for myocardial infarction therapy: Mechanistic insights and translational opportunities
title_full_unstemmed Harnessing natural products for myocardial infarction therapy: Mechanistic insights and translational opportunities
title_short Harnessing natural products for myocardial infarction therapy: Mechanistic insights and translational opportunities
title_sort harnessing natural products for myocardial infarction therapy mechanistic insights and translational opportunities
topic Natural products
Myocardial infarction
Pathological mechanism
Target identification
Drug delivery system
url http://www.sciencedirect.com/science/article/pii/S1043661825002270
work_keys_str_mv AT mengmengli harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities
AT siyiwang harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities
AT hanyadong harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities
AT minwang harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities
AT yesun harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities
AT yubi harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities
AT lixiachen harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities
AT anamnaseem harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities
AT haijiang harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities
AT huali harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities
AT bingyouyang harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities
AT yanliu harnessingnaturalproductsformyocardialinfarctiontherapymechanisticinsightsandtranslationalopportunities